PATENT CLAIM ANALYSIS

Application Number: 16084357
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

Claim (Index 16):
The method of  claim 11 , wherein the cancer is CML.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13806069', '14538939', '12612943', '13989603', '14772566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736457871201866
- 35 USC 102 Novelty (BERT): 0.5464208754343484
- Combined Prediction Score: 0.7509232959516028
- Mean Citation Score: 324.5298160000001
- Max Citation Score: 395.75055
- Similarity Product: 208.2959272239357

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test